{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T04:11:30Z","timestamp":1790136690231,"version":"4.0.1"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1093\/neuonc\/nor101","type":"journal-article","created":{"date-parts":[[2011,7,29]],"date-time":"2011-07-29T00:50:05Z","timestamp":1311900605000},"page":"1125-1132","source":"Crossref","is-referenced-by-count":23,"title":["Increased growth rate of vestibular schwannoma after resection of contralateral tumor in neurofibromatosis type 2"],"prefix":"10.1093","volume":"13","author":[{"given":"Matthieu","family":"Peyre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephane","family":"Goutagny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Imbeaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Bozorg-Grayeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Felce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Sterkers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Kalamarides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2011,7,28]]},"reference":[{"issue":"1","key":"key\n\t\t\t\t20170508160345_NOR101C1","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/00129492-200501000-00016","article-title":"Incidence of vestibular schwannoma and neurofibromatosis 2 in the North West of England over a 10-year period: higher incidence than previously thought","volume":"26","author":"Evans","year":"2005","journal-title":"Otol Neurotol"},{"issue":"2","key":"key\n\t\t\t\t20170508160345_NOR101C2","first-page":"274","article-title":"Early proactive management of vestibular schwannomas in neurofibromatosis type 2","volume":"49","author":"Brackmann","year":"2001","journal-title":"Neurosurgery"},{"issue":"4","key":"key\n\t\t\t\t20170508160345_NOR101C3","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1097\/00006123-199704000-00007","article-title":"Management of vestibular schwannomas (acoustic neuromas): auditory and facial nerve function after resection of 120 vestibular schwannomas in patients with neurofibromatosis 2","volume":"40","author":"Samii","year":"1997","journal-title":"Neurosurgery"},{"issue":"1","key":"key\n\t\t\t\t20170508160345_NOR101C4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3171\/jns.2001.94.1.0001","article-title":"Results of acoustic neuroma radiosurgery: an analysis of 5 years' experience using current methods","volume":"94","author":"Flickinger","year":"2001","journal-title":"J Neurosurg"},{"issue":"16","key":"key\n\t\t\t\t20170508160345_NOR101C5","doi-asserted-by":"crossref","first-page":"5032","DOI":"10.1158\/1078-0432.CCR-08-3011","article-title":"Consensus recommendations to accelerate clinical trials for neurofibromatosis type 2","volume":"15","author":"Evans","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"8","key":"key\n\t\t\t\t20170508160345_NOR101C6","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/ncponc1157","article-title":"Audiologic and radiographic response of NF2-related vestibular schwannoma to erlotinib therapy","volume":"5","author":"Plotkin","year":"2008","journal-title":"Nat Clin Pract Oncol"},{"issue":"1","key":"key\n\t\t\t\t20170508160345_NOR101C7","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/neuonc\/nop010","article-title":"Bevacizumab induces regression of vestibular schwannomas in patients with neurofibromatosis type 2","volume":"12","author":"Mautner","year":"2010","journal-title":"Neuro Oncol"},{"issue":"5","key":"key\n\t\t\t\t20170508160345_NOR101C8","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1097\/00129492-200409000-00027","article-title":"Vestibular schwannoma growth rates in neurofibromatosis type 2 natural history consortium subjects","volume":"25","author":"Slattery","year":"2004","journal-title":"Otol Neurotol"},{"issue":"6","key":"key\n\t\t\t\t20170508160345_NOR101C9","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1097\/00005537-199606000-00007","article-title":"Growth rate characteristics of acoustic neuromas associated with neurofibromatosis type 2","volume":"106","author":"Abaza","year":"1996","journal-title":"Laryngoscope"},{"issue":"2","key":"key\n\t\t\t\t20170508160345_NOR101C10","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3171\/jns.2002.96.2.0217","article-title":"Predictors of vestibular schwannoma growth in patients with neurofibromatosis type 2","volume":"96","author":"Baser","year":"2002","journal-title":"J Neurosurg"},{"issue":"2","key":"key\n\t\t\t\t20170508160345_NOR101C11","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3171\/jns.2002.96.2.0223","article-title":"Vestibular schwannoma growth in patients with neurofibromatosis type 2: a longitudinal study","volume":"96","author":"Mautner","year":"2002","journal-title":"J Neurosurg"},{"issue":"4","key":"key\n\t\t\t\t20170508160345_NOR101C12","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s10143-009-0223-3","article-title":"Factors predicting growth of vestibular schwannoma in neurofibromatosis type 2","volume":"32","author":"Ito","year":"2009","journal-title":"Neurosurg Rev"},{"issue":"8","key":"key\n\t\t\t\t20170508160345_NOR101C13","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1097\/MAO.0b013e31818b6238","article-title":"Auditory brainstem implant in neurofibromatosis type 2 and non-neurofibromatosis type 2 patients","volume":"29","author":"Grayeli","year":"2008","journal-title":"Otol Neurotol"},{"issue":"12","key":"key\n\t\t\t\t20170508160345_NOR101C14","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1136\/jmg.2005.031302","article-title":"Methodological issues in longitudinal studies: vestibular schwannoma growth rates in neurofibromatosis 2","volume":"42","author":"Baser","year":"2005","journal-title":"J Med Genet"},{"issue":"6","key":"key\n\t\t\t\t20170508160345_NOR101C15","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1227\/01.neu.0000333303.79931.83","article-title":"Three-dimensional volumetrics for tracking vestibular schwannoma growth in neurofibromatosis type II","volume":"62","author":"Harris","year":"2008","journal-title":"Neurosurgery"},{"issue":"4","key":"key\n\t\t\t\t20170508160345_NOR101C16","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/ana.10528","article-title":"Continuous growth of mean tumor diameter in a subset of grade II gliomas","volume":"53","author":"Mandonnet","year":"2003","journal-title":"Ann Neurol"},{"issue":"4","key":"key\n\t\t\t\t20170508160345_NOR101C17","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1097\/00129492-200307000-00019","article-title":"New and modified reporting systems from the consensus meeting on systems for reporting results in vestibular schwannoma","volume":"24","author":"Kanzaki","year":"2003","journal-title":"Otol Neurotol"},{"issue":"5","key":"key\n\t\t\t\t20170508160345_NOR101C18","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.3171\/2010.11.JNS101041","article-title":"Clinicopathological factors related to regrowth of vestibular schwannoma after incomplete resection","volume":"114","author":"Fukuda","year":"2011","journal-title":"J Neurosurg"},{"issue":"1","key":"key\n\t\t\t\t20170508160345_NOR101C19","first-page":"30","article-title":"Expression of Ki-67 antigen and vascular endothelial growth factor in sporadic and neurofibromatosis type 2-associated schwannomas","volume":"22","author":"Saito","year":"2003","journal-title":"Clin Neuropathol"},{"issue":"47","key":"key\n\t\t\t\t20170508160345_NOR101C20","doi-asserted-by":"crossref","first-page":"6216","DOI":"10.1038\/onc.2010.363","article-title":"Rates of loss of heterozygosity and mitotic recombination in NF2 schwannomas, sporadic vestibular schwannomas and schwannomatosis schwannomas","volume":"29","author":"Hadfield","year":"2010","journal-title":"Oncogene"},{"issue":"1","key":"key\n\t\t\t\t20170508160345_NOR101C21","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3171\/2009.5.JNS09240","article-title":"Spontaneous regression of vestibular schwannomas after resection of contralateral tumor in neurofibromatosis type 2","volume":"112","author":"von Eckardstein","year":"2010","journal-title":"J Neurosurg"},{"issue":"1","key":"key\n\t\t\t\t20170508160345_NOR101C22","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3171\/jns.1998.89.1.0149","article-title":"Neurofibromatosis type 2: growth stimulation of mixed acoustic schwannoma by concurrent adjacent meningioma: possible role of growth factors. Case report","volume":"89","author":"Pallini","year":"1998","journal-title":"J Neurosurg"},{"issue":"4","key":"key\n\t\t\t\t20170508160345_NOR101C23","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1749-4486.2010.02176.x","article-title":"The relationship between patients' perception of the effects of neurofibromatosis type 2 and the domains of the short form-36","volume":"35","author":"Neary","year":"2010","journal-title":"Clin Otolaryngol"},{"issue":"7","key":"key\n\t\t\t\t20170508160345_NOR101C24","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1017\/S0022215110000460","article-title":"Use of a closed set questionnaire to measure primary and secondary effects of neurofibromatosis type 2","volume":"124","author":"Neary","year":"2010","journal-title":"J Laryngol Otol"},{"issue":"3","key":"key\n\t\t\t\t20170508160345_NOR101C25","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1227\/01.NEU.0000255340.26027.53","article-title":"Stereotactic radiosurgery for vestibular schwannomas in patients with neurofibromatosis type 2: an analysis of tumor control, complications, and hearing preservation rates","volume":"60","author":"Mathieu","year":"2007","journal-title":"Neurosurgery"},{"issue":"2","key":"key\n\t\t\t\t20170508160345_NOR101C26","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/cncr.24036","article-title":"Radiosurgical treatment of vestibular schwannomas in patients with neurofibromatosis type 2: tumor control and hearing preservation","volume":"115","author":"Phi","year":"2009","journal-title":"Cancer"},{"issue":"9","key":"key\n\t\t\t\t20170508160345_NOR101C27","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1136\/jnnp.74.9.1288","article-title":"Clinical experience with gamma knife stereotactic radiosurgery in the management of vestibular schwannomas secondary to type 2 neurofibromatosis","volume":"74","author":"Rowe","year":"2003","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/13\/10\/1125\/16663072\/nor101.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,23]],"date-time":"2017-08-23T19:51:10Z","timestamp":1503517870000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article-lookup\/doi\/10.1093\/neuonc\/nor101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,28]]},"references-count":27,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2011,7,28]]},"published-print":{"date-parts":[[2011,10]]}},"URL":"https:\/\/doi.org\/10.1093\/neuonc\/nor101","relation":{},"ISSN":["1523-5866","1522-8517"],"issn-type":[{"value":"1523-5866","type":"electronic"},{"value":"1522-8517","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7,28]]}}}